Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Pulmonary manifestations in malaria.

Identifieur interne : 000475 ( PubMed/Curation ); précédent : 000474; suivant : 000476

Pulmonary manifestations in malaria.

Auteurs : R. Rajput ; H. Singh ; S. Singh ; Meena ; U C Tiwari

Source :

RBID : pubmed:11258488

Descripteurs français

English descriptors

Abstract

Malaria, a major killer of mankind, apart from classical ague presentation, may present with respiratory manifestations. This may be misdiagnosed and important time may be lost in instituting antimalarials leading to higher morbidity and mortality. Present work was undertaken to study the clinical presentations of malaria with special reference to respiratory system and to evaluate the effect of antimalarials to such atypical presentation. One hundred slide positive cases of malaria were taken and detailed for respiratory involvement. Response to antimalarials was seen in these cases and associated complications (if any) were looked for. Mean age of the cases was 29.3 years with a male predominance. Positivity of peripheral smear read as: P vivax(53%), P falciparum (36%) and mixed infection (11%). Twenty-six patients had presented with respiratory manifestations-bronchitis (15), pneumonia (4), asthmatic bronchitis (1), adult respiratory distress syndrome (ARDS) (4) and pulmonary tuberculosis (2). Of these 26 cases, presenting symptoms noticed were cough (77%), dyspnoea (32%), expectoration (29%) and chest pain (15%). Twenty-five (96%) of these 26 patients were positive for P falciparum. Response to antimalarials was not significantly different in these 26 patients as compared to the rest (74 cases). All patients developing ARDS expired. The present study concludes that malarial atypical respiratory presentations are far higher in incidence than reported in literature. Peripheral smear examination in all patients of high grade fever with chills and rigors and having respiratory manifestations may unmask malarial infection and warrant early antimalarial treatment resulting in decreased morbidity and mortality.

PubMed: 11258488

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:11258488

Curation

No country items

R. Rajput
<affiliation>
<nlm:affiliation>Department of Medicine, Pt BD Sharma Postgraduate Institute of Medical Sciences, Rohtak.</nlm:affiliation>
<wicri:noCountry code="subField">Rohtak</wicri:noCountry>
</affiliation>

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Pulmonary manifestations in malaria.</title>
<author>
<name sortKey="Rajput, R" sort="Rajput, R" uniqKey="Rajput R" first="R" last="Rajput">R. Rajput</name>
<affiliation>
<nlm:affiliation>Department of Medicine, Pt BD Sharma Postgraduate Institute of Medical Sciences, Rohtak.</nlm:affiliation>
<wicri:noCountry code="subField">Rohtak</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Singh, H" sort="Singh, H" uniqKey="Singh H" first="H" last="Singh">H. Singh</name>
</author>
<author>
<name sortKey="Singh, S" sort="Singh, S" uniqKey="Singh S" first="S" last="Singh">S. Singh</name>
</author>
<author>
<name sortKey="Meena" sort="Meena" uniqKey="Meena" last="Meena">Meena</name>
</author>
<author>
<name sortKey="Tiwari, U C" sort="Tiwari, U C" uniqKey="Tiwari U" first="U C" last="Tiwari">U C Tiwari</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:11258488</idno>
<idno type="pmid">11258488</idno>
<idno type="wicri:Area/PubMed/Corpus">000475</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000475</idno>
<idno type="wicri:Area/PubMed/Curation">000475</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000475</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Pulmonary manifestations in malaria.</title>
<author>
<name sortKey="Rajput, R" sort="Rajput, R" uniqKey="Rajput R" first="R" last="Rajput">R. Rajput</name>
<affiliation>
<nlm:affiliation>Department of Medicine, Pt BD Sharma Postgraduate Institute of Medical Sciences, Rohtak.</nlm:affiliation>
<wicri:noCountry code="subField">Rohtak</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Singh, H" sort="Singh, H" uniqKey="Singh H" first="H" last="Singh">H. Singh</name>
</author>
<author>
<name sortKey="Singh, S" sort="Singh, S" uniqKey="Singh S" first="S" last="Singh">S. Singh</name>
</author>
<author>
<name sortKey="Meena" sort="Meena" uniqKey="Meena" last="Meena">Meena</name>
</author>
<author>
<name sortKey="Tiwari, U C" sort="Tiwari, U C" uniqKey="Tiwari U" first="U C" last="Tiwari">U C Tiwari</name>
</author>
</analytic>
<series>
<title level="j">Journal of the Indian Medical Association</title>
<idno type="ISSN">0019-5847</idno>
<imprint>
<date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Animals</term>
<term>Antimalarials (therapeutic use)</term>
<term>Chloroquine (therapeutic use)</term>
<term>Female</term>
<term>Humans</term>
<term>Lung Diseases (etiology)</term>
<term>Malaria, Falciparum (blood)</term>
<term>Malaria, Falciparum (complications)</term>
<term>Malaria, Falciparum (epidemiology)</term>
<term>Malaria, Vivax (blood)</term>
<term>Malaria, Vivax (complications)</term>
<term>Malaria, Vivax (epidemiology)</term>
<term>Male</term>
<term>Plasmodium falciparum (drug effects)</term>
<term>Plasmodium vivax (drug effects)</term>
<term>Quinine (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Animaux</term>
<term>Antipaludiques (usage thérapeutique)</term>
<term>Chloroquine (usage thérapeutique)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Maladies pulmonaires (étiologie)</term>
<term>Mâle</term>
<term>Paludisme à Plasmodium falciparum ()</term>
<term>Paludisme à Plasmodium falciparum (sang)</term>
<term>Paludisme à Plasmodium falciparum (épidémiologie)</term>
<term>Paludisme à Plasmodium vivax ()</term>
<term>Paludisme à Plasmodium vivax (sang)</term>
<term>Paludisme à Plasmodium vivax (épidémiologie)</term>
<term>Plasmodium falciparum ()</term>
<term>Plasmodium vivax ()</term>
<term>Quinine (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antimalarials</term>
<term>Chloroquine</term>
<term>Quinine</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en">
<term>Malaria, Falciparum</term>
<term>Malaria, Vivax</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Malaria, Falciparum</term>
<term>Malaria, Vivax</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Plasmodium falciparum</term>
<term>Plasmodium vivax</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Malaria, Falciparum</term>
<term>Malaria, Vivax</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Lung Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Paludisme à Plasmodium falciparum</term>
<term>Paludisme à Plasmodium vivax</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antipaludiques</term>
<term>Chloroquine</term>
<term>Quinine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Paludisme à Plasmodium falciparum</term>
<term>Paludisme à Plasmodium vivax</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Maladies pulmonaires</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Animals</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Animaux</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Paludisme à Plasmodium falciparum</term>
<term>Paludisme à Plasmodium vivax</term>
<term>Plasmodium falciparum</term>
<term>Plasmodium vivax</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Malaria, a major killer of mankind, apart from classical ague presentation, may present with respiratory manifestations. This may be misdiagnosed and important time may be lost in instituting antimalarials leading to higher morbidity and mortality. Present work was undertaken to study the clinical presentations of malaria with special reference to respiratory system and to evaluate the effect of antimalarials to such atypical presentation. One hundred slide positive cases of malaria were taken and detailed for respiratory involvement. Response to antimalarials was seen in these cases and associated complications (if any) were looked for. Mean age of the cases was 29.3 years with a male predominance. Positivity of peripheral smear read as: P vivax(53%), P falciparum (36%) and mixed infection (11%). Twenty-six patients had presented with respiratory manifestations-bronchitis (15), pneumonia (4), asthmatic bronchitis (1), adult respiratory distress syndrome (ARDS) (4) and pulmonary tuberculosis (2). Of these 26 cases, presenting symptoms noticed were cough (77%), dyspnoea (32%), expectoration (29%) and chest pain (15%). Twenty-five (96%) of these 26 patients were positive for P falciparum. Response to antimalarials was not significantly different in these 26 patients as compared to the rest (74 cases). All patients developing ARDS expired. The present study concludes that malarial atypical respiratory presentations are far higher in incidence than reported in literature. Peripheral smear examination in all patients of high grade fever with chills and rigors and having respiratory manifestations may unmask malarial infection and warrant early antimalarial treatment resulting in decreased morbidity and mortality.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">11258488</PMID>
<DateCompleted>
<Year>2001</Year>
<Month>08</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0019-5847</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>98</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2000</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Journal of the Indian Medical Association</Title>
<ISOAbbreviation>J Indian Med Assoc</ISOAbbreviation>
</Journal>
<ArticleTitle>Pulmonary manifestations in malaria.</ArticleTitle>
<Pagination>
<MedlinePgn>612-4</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Malaria, a major killer of mankind, apart from classical ague presentation, may present with respiratory manifestations. This may be misdiagnosed and important time may be lost in instituting antimalarials leading to higher morbidity and mortality. Present work was undertaken to study the clinical presentations of malaria with special reference to respiratory system and to evaluate the effect of antimalarials to such atypical presentation. One hundred slide positive cases of malaria were taken and detailed for respiratory involvement. Response to antimalarials was seen in these cases and associated complications (if any) were looked for. Mean age of the cases was 29.3 years with a male predominance. Positivity of peripheral smear read as: P vivax(53%), P falciparum (36%) and mixed infection (11%). Twenty-six patients had presented with respiratory manifestations-bronchitis (15), pneumonia (4), asthmatic bronchitis (1), adult respiratory distress syndrome (ARDS) (4) and pulmonary tuberculosis (2). Of these 26 cases, presenting symptoms noticed were cough (77%), dyspnoea (32%), expectoration (29%) and chest pain (15%). Twenty-five (96%) of these 26 patients were positive for P falciparum. Response to antimalarials was not significantly different in these 26 patients as compared to the rest (74 cases). All patients developing ARDS expired. The present study concludes that malarial atypical respiratory presentations are far higher in incidence than reported in literature. Peripheral smear examination in all patients of high grade fever with chills and rigors and having respiratory manifestations may unmask malarial infection and warrant early antimalarial treatment resulting in decreased morbidity and mortality.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rajput</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Pt BD Sharma Postgraduate Institute of Medical Sciences, Rohtak.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Meena</LastName>
</Author>
<Author ValidYN="Y">
<LastName>Tiwari</LastName>
<ForeName>U C</ForeName>
<Initials>UC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>India</Country>
<MedlineTA>J Indian Med Assoc</MedlineTA>
<NlmUniqueID>7505608</NlmUniqueID>
<ISSNLinking>0019-5847</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>A7V27PHC7A</RegistryNumber>
<NameOfSubstance UI="D011803">Quinine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016778" MajorTopicYN="N">Malaria, Falciparum</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016780" MajorTopicYN="N">Malaria, Vivax</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010963" MajorTopicYN="N">Plasmodium falciparum</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010966" MajorTopicYN="N">Plasmodium vivax</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011803" MajorTopicYN="N">Quinine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2001</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2001</Year>
<Month>8</Month>
<Day>17</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2001</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">11258488</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000475 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000475 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:11258488
   |texte=   Pulmonary manifestations in malaria.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:11258488" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021